Evaluation Study of the Intestinal Microbiota and Quality of Life in Patients Suffering From IBS Treated With Bifidice
NACompletedINTERVENTIONAL
Enrollment
8
Participants
Timeline
Start Date
December 13, 2022
Primary Completion Date
December 31, 2023
Study Completion Date
December 31, 2023
Conditions
Irritable Bowel Syndrome
Interventions
DRUG
Probiotic Formula
Probiotic Formula
Trial Locations (1)
20089
Humanitas Research Hospital, Milan
All Listed Sponsors
lead
Istituto Clinico Humanitas
OTHER
NCT05663060 - Evaluation Study of the Intestinal Microbiota and Quality of Life in Patients Suffering From IBS Treated With Bifidice | Biotech Hunter | Biotech Hunter